NCT02462187 2023-04-06
Topical NVN1000 for the Treatment of External Genital and Perianal Warts
Novan, Inc.
Phase 2 Completed
Clinical Trials
3 trialsNCT02724254 2018-07-20
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients
Vaxart
Phase 2 Completed
NCT02849262 2017-03-31
Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts
Maruho Co., Ltd.
Phase 2 Completed